HomeCompareLRDRD vs JNJ

LRDRD vs JNJ: Dividend Comparison 2026

LRDRD yields 666.67% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LRDRD wins by $608115.64M in total portfolio value
10 years
LRDRD
LRDRD
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full LRDRD calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — LRDRD vs JNJ

📍 LRDRD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLRDRDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LRDRD + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LRDRD pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LRDRD
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, LRDRD beats the other by $399,126,865,290.20/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LRDRD + JNJ for your $10,000?

LRDRD: 50%JNJ: 50%
100% JNJ50/50100% LRDRD
Portfolio after 10yr
$304057.84M
Annual income
$234,780,509,822.01/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

LRDRD
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LRDRD buys
0
JNJ buys
0
No recent congressional trades found for LRDRD or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLRDRDJNJ
Forward yield666.67%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$608115.66M$20.0K
Annual income after 10y$469,561,018,816.25$827.78
Total dividends collected$596792.85M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LRDRD vs JNJ ($10,000, DRIP)

YearLRDRD PortfolioLRDRD Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$77,367$66,666.67$10,676$355.77+$66.7KLRDRD
2$564,818$482,035.31$11,407$389.39+$553.4KLRDRD
3$3,893,246$3,288,890.67$12,198$426.53+$3.88MLRDRD
4$25,352,760$21,186,987.16$13,056$467.62+$25.34MLRDRD
5$156,070,781$128,943,327.59$13,987$513.12+$156.06MLRDRD
6$908,837,800$741,842,064.29$14,998$563.56+$908.82MLRDRD
7$5,009,769,782$4,037,313,336.56$16,098$619.52+$5009.75MLRDRD
8$26,159,339,258$20,798,885,591.56$17,295$681.69+$26159.32MLRDRD
9$129,490,317,125$101,499,824,118.87$18,599$750.82+$129490.30MLRDRD
10$608,115,658,140$469,561,018,816.25$20,022$827.78+$608115.64MLRDRD

LRDRD vs JNJ: Complete Analysis 2026

LRDRDStock

LRDRD is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in LRDRD shares.

Full LRDRD Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this LRDRD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LRDRD vs SCHDLRDRD vs JEPILRDRD vs OLRDRD vs KOLRDRD vs MAINLRDRD vs ABBVLRDRD vs MRKLRDRD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.